Advancements in Targeted Drug Delivery Systems: Current Trends and Future Perspectives

Abstract

Targeted drug delivery systems have emerged as a transformative approach in modern pharmacology, offering improved therapeutic efficacy while minimizing adverse effects associated with conventional drug administration. These systems are designed to deliver pharmaceutical agents directly to specific tissues, cells, or organs, thereby enhancing drug concentration at the desired site of action and reducing systemic exposure. Recent advancements in nanotechnology, biotechnology, and material sciences have significantly contributed to the development of innovative drug carriers, including nanoparticles, liposomes, dendrimers, micelles, and polymer-based delivery systems. These technologies have shown considerable promise in the treatment of various diseases, particularly cancer, cardiovascular disorders, neurological conditions, and infectious diseases. Current research focuses on improving targeting accuracy through active and passive targeting mechanisms, stimulus-responsive delivery systems, and the integration of artificial intelligence for personalized therapy. Furthermore, advancements in gene delivery, biologics, and controlled-release formulations have expanded the scope of targeted therapeutics. Despite these developments, challenges such as biocompatibility, manufacturing complexity, regulatory approval, and long-term safety remain significant concerns. the recent trends in targeted drug delivery systems, highlights their clinical applications, the challenges associated with their development, and explores future perspectives aimed at enhancing treatment outcomes and patient care. The continued evolution of targeted drug delivery technologies is expected to play a crucial role in the advancement of precision medicine and next-generation therapeutics.